Literature DB >> 22737046

A Review of Smoking Cessation in Bipolar Disorder: Implications for Future Research.

Tony P George1, Becky S Wu, Andrea H Weinberger.   

Abstract

Tobacco smoking is common in people with bipolar disorder, and rates of smoking cessation are lower than in the general population. A literature review found eleven clinical research publications on bipolar disorder and tobacco, including only one smoking cessation pharmacotherapy trial. This article will review these findings and discuss possible reasons for the high rates of tobacco addiction among persons with bipolar disorder, as well as specific vulnerability factors that may contribute to tobacco treatment failure. An approach to the clinical assessment and treatment of tobacco dependence is described for this sub-group of smokers. Finally, recommendations are made for planning future treatment studies in persons with bipolar disorder and nicotine dependence.

Entities:  

Year:  2012        PMID: 22737046      PMCID: PMC3378056          DOI: 10.1080/15504263.2012.671717

Source DB:  PubMed          Journal:  J Dual Diagn        ISSN: 1550-4271


  39 in total

1.  Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder.

Authors:  L Elliot Hong; Gunvant K Thaker; Robert P McMahon; Ann Summerfelt; Jill Rachbeisel; Rebecca L Fuller; Ikwunga Wonodi; Robert W Buchanan; Carol Myers; Stephen J Heishman; Jeff Yang; Adrienne Nye
Journal:  Arch Gen Psychiatry       Date:  2011-08-01

2.  Smoking outcome by psychiatric history after behavioral and varenicline treatment.

Authors:  Jennifer B McClure; Gary E Swan; Sheryl L Catz; Lisa Jack; Harold Javitz; Tim McAfee; Mona Deprey; Julie Richards; Susan M Zbikowski
Journal:  J Subst Abuse Treat       Date:  2010-04-02

3.  Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.

Authors:  Douglas E Jorenby; J Taylor Hays; Nancy A Rigotti; Salomon Azoulay; Eric J Watsky; Kathryn E Williams; Clare B Billing; Jason Gong; Karen R Reeves
Journal:  JAMA       Date:  2006-07-05       Impact factor: 56.272

4.  Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms.

Authors:  Kristi A Sacco; Angelo Termine; Aisha Seyal; Melissa M Dudas; Jennifer C Vessicchio; Suchitra Krishnan-Sarin; Peter I Jatlow; Bruce E Wexler; Tony P George
Journal:  Arch Gen Psychiatry       Date:  2005-06

5.  Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial.

Authors:  Miles McFall; Andrew J Saxon; Carol A Malte; Bruce Chow; Sara Bailey; Dewleen G Baker; Jean C Beckham; Kathy D Boardman; Timothy P Carmody; Anne M Joseph; Mark W Smith; Mei-Chiung Shih; Ying Lu; Mark Holodniy; Philip W Lavori
Journal:  JAMA       Date:  2010-12-08       Impact factor: 56.272

6.  A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder.

Authors:  Jill M Williams; Robert M Anthenelli; Chad D Morris; Joan Treadow; John R Thompson; Carla Yunis; Tony P George
Journal:  J Clin Psychiatry       Date:  2012-05       Impact factor: 4.384

7.  Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness.

Authors:  John A Stapleton; Lucy Watson; Lucy I Spirling; Robert Smith; Andrea Milbrandt; Marina Ratcliffe; Gay Sutherland
Journal:  Addiction       Date:  2007-11-19       Impact factor: 6.526

8.  Lifestyle characteristics of psychiatric outpatients.

Authors:  Henry T Chuang; Craig Mansell; Scott B Patten
Journal:  Can J Psychiatry       Date:  2008-04       Impact factor: 4.356

9.  A preliminary study of sustained-release bupropion for smoking cessation in bipolar disorder.

Authors:  Andrea H Weinberger; Jennifer C Vessicchio; Kristi A Sacco; Cerissa L Creeden; K N Roy Chengappa; Tony P George
Journal:  J Clin Psychopharmacol       Date:  2008-10       Impact factor: 3.153

10.  Relation between cigarette smoking and cognitive function in euthymic individuals with bipolar disorder.

Authors:  Candy W Y Law; Joanna K Soczynska; Hanna O Woldeyohannes; Andrew Miranda; John O Brooks; Roger S McIntyre
Journal:  Pharmacol Biochem Behav       Date:  2008-10-22       Impact factor: 3.533

View more
  8 in total

Review 1.  Treatment of tobacco use disorders in smokers with serious mental illness: toward clinical best practices.

Authors:  A Eden Evins; Corinne Cather; Alexandra Laffer
Journal:  Harv Rev Psychiatry       Date:  2015 Mar-Apr       Impact factor: 3.732

Review 2.  Tobacco use treatment in primary care patients with psychiatric illness.

Authors:  Joseph M Cerimele; Abigail C Halperin; Andrew J Saxon
Journal:  J Am Board Fam Med       Date:  2014 May-Jun       Impact factor: 2.657

3.  A Preliminary Feasibility Study of Varenicline for Smoking Cessation in Bipolar Disorder.

Authors:  Becky S Wu; Andrea H Weinberger; Enza Mancuso; Victoria C Wing; Bahar Haji-Khamneh; Andrea J Levinson; Tony P George
Journal:  J Dual Diagn       Date:  2012-03-20

4.  Cancer screening, prevention, and treatment in people with mental illness.

Authors:  Lara C Weinstein; Ana Stefancic; Amy T Cunningham; Katelyn E Hurley; Leopodo J Cabassa; Richard C Wender
Journal:  CA Cancer J Clin       Date:  2015-12-10       Impact factor: 508.702

5.  Safety and efficacy of first-line smoking cessation pharmacotherapies in bipolar disorders: Subgroup analysis of a randomized clinical trial.

Authors:  Jaimee L Heffner; A Eden Evins; Cristina Russ; David Lawrence; Catherine R Ayers; Thomas McRae; Lisa St Aubin; Alok Krishen; Robert West; Robert M Anthenelli
Journal:  J Affect Disord       Date:  2019-06-03       Impact factor: 4.839

Review 6.  Smoking Use and Cessation Among People with Serious Mental Illness.

Authors:  Aniyizhai Annamalai; Noreen Singh; Stephanie S O'Malley
Journal:  Yale J Biol Med       Date:  2015-09-03

7.  Tobacco use in bipolar disorder.

Authors:  Daniel Thomson; Michael Berk; Seetal Dodd; Marta Rapado-Castro; Shae E Quirk; Pernille K Ellegaard; Lesley Berk; Olivia M Dean
Journal:  Clin Psychopharmacol Neurosci       Date:  2015-04-30       Impact factor: 2.582

8.  Effectiveness of the Gold Standard Programme (GSP) for smoking cessation on smokers with and without a severe mental disorder: a Danish cohort study.

Authors:  Mette Rasmussen; Mads Klinge; Jesper Krogh; Merete Nordentoft; Hanne Tønnesen
Journal:  BMJ Open       Date:  2018-06-11       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.